Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range

September 9, 2025 by Projesh Kar

[ad_1]

Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry of acquisitions at a similar price point.

[ad_2]

Projesh Kar

I am a passionate blogger with extensive experience in web design. As a seasoned YouTube SEO expert, I have helped numerous creators optimize their content for maximum visibility.

Contact